logo

TVRD

Tvardi Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.62 / 10
Netural

Fund-flow sentiment is positive with a 7.25/10 score, reflecting solid capital inflow across block, small, medium, and large orders despite a negative overall trend. Analyst coverage is moderate (3 analysts) with ratings split: Strong Buy (33.3%), Buy (33.3%), Neutral (33.3%). Historical win rates for these predictions are low (0.0%), and the market-weighted rating is 0.0%, indicating limited confidence. The combination suggests that while money is entering, analyst conviction is weak, and price action has been falling (-14.29%).

FundamentalSentiment(3.62)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

33%

Buy

33%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-10-13
InstitutionBarclays
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of TVRD?
  • TVRD holds a Bearish analyst rating, with 33% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.62/10 (Netural).